Myopia Control Combined PBM With Myopic Defocus Lens in Children
ConditionMyopia, Progressive
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age6-13
SponsorBeijing Airdoc Technology Co., Ltd.
About this trial
To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.
Eligibility criteria
Qualifiers
Informed consent by the supervision of the children
6~13 years old (including both the 6 and 13)
SE range: -0.50~-5.50D
Astigmatism <=2.00D
Disqualifiers
Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential opitc abnormal and etc.)
Halo, glare, toutic, ADHD, psoriasis
Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction.
Squint, ocular lesion or acute imflammation.
Trial design
Treatments tested in this trial
- PBM
- Peripheral defocus spectacles
- Single vision spectacles
Treatment groups
304 Participants
are divided into 4 treatment groupsSponsors and collaborators
Beijing Airdoc Technology Co., Ltd.
Lead sponsor
The First People's Hospital of Xuzhou
Collaborator
Source ClinicalTrials.gov